Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2021 May Covid-19 ‘Our COVID algorithm is still up-to-date and in use in every Belgian hospital’ Read more
2021 May Covid-19 Vaccinating into skin instead of muscles could mean many more people can be immunized Read more
2021 May Editor's pick Editor’s pick of Sylvia Snauwaert: relevant literature for your daily practice Read more
Top
